Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and maltol

resveratrol has been researched along with maltol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Chen, J; Cheng, G; Ma, Y; Sheng, R; Xu, P; Zhang, M1
Barić, D; Fodor, L; Horváth, O; Lasić, Z; Lovrić, MJ; Marinić, Ž; Milašinović, V; Mlakić, M; Molčanov, K; Odak, I; Škorić, I1

Other Studies

3 other study(ies) available for resveratrol and maltol

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease.
    Bioorganic & medicinal chemistry, 2018, 12-01, Volume: 26, Issue:22

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Benzothiazoles; Chelating Agents; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Pyrones; Resveratrol; Structure-Activity Relationship; Sulfonic Acids

2018
Resveratrol-Maltol and Resveratrol-Thiophene Hybrids as Cholinesterase Inhibitors and Antioxidants: Synthesis, Biometal Chelating Capability and Crystal Structure.
    Molecules (Basel, Switzerland), 2022, Sep-27, Volume: 27, Issue:19

    Topics: Alzheimer Disease; Antioxidants; Chelating Agents; Cholinesterase Inhibitors; Cholinesterases; Galantamine; Humans; Ligands; Molecular Docking Simulation; Pyrones; Resveratrol; Structure-Activity Relationship; Thiophenes; Trace Elements

2022